Skip to content

FP7HORIZONH2020

Medical Research Infrastructure Development and Health Services Fund By the Sheba Medical Center

Country
ILIsrael
Defence projects
0
Projects, all programmes
32
As coordinator
10
EU contribution (CORDIS)
EUR 12,337,323
Active
2008 to 2025

Projects

32 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
RECURRENT GLIOMA TXPhase I trial in recurrent high-grade glioma: High-dose vorinostat with concurrent hypofractionated radiation therapyFP72013CoordinatorEUR 100,000
WINTHERWINTHERapeutics: development of a systems biology method to predict efficacy of cancer drugs to optimize individualized therapeutic decision and improve clinical outcome for cancer patientsFP72013ParticipantEUR 315,813
ABIRISKAnti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the riskFP72012ParticipantEUR 12,680
NEPHROTOOLSThe potential of human kidney stem/progenitor cells for use in drug discovery and regenerative therapy programmesFP72011ParticipantEUR 239,740
CVM THERAPYAngiogenesis Research to Improve Therapies for Vascular MalformationsFP72011CoordinatorEUR 100,000
SAVEMEA Modular Nanosystems Platform for Advanced Cancer Management: Nano-vehicles; Tumor Targeting and Penetration Agents; Molecular Imaging, Degradome based TherapyFP72011ParticipantEUR 873,865
NEVUS CLASSIFICATIONClassification and longitudinal follow-up of common melanocytic nevi with in vivo reflectance confocal microscopyFP72011CoordinatorEUR 100,000
EUSARNADJoint European and South African Research Network in Anxiety DisordersFP72011ParticipantEUR 8,400
OPTIMISEOPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE)FP72010ParticipantEUR 224,073
ROLE OF SPISThe role of Salmonella Pathogenicity Islands in salmonellosis outbreaks and invasive diseaseFP72010CoordinatorEUR 100,000
NANOIINanoscopically-guided induction and expansion of regulatory hematopoietic cells to treat autoimmune and inflammatory processesFP72009ParticipantEUR 200,000
CANCER EPIGENETICSComprehensive characterization of epigentic reprogramming in cancerFP72008CoordinatorEUR 100,000

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.